Headline News about Atea Pharmaceuticals Inc![]() ![]() ![]()
How Atea's Clinical Flop Shakes Up the COVID-19 Pill Market
October 29, 2021
Via The Motley Fool
Exposures
COVID-19
![]() ![]()
3 Top COVID Stocks -- Are They Tricks or Treats?
October 26, 2021
Via The Motley Fool
Exposures
COVID-19
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher
October 19, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance
October 19, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
![]() ![]() ![]() ![]() ![]()
Molnupiravir? Not So Fast. What About Tollovir? — Here's Why You Should Know What That Means
October 12, 2021
Via Benzinga
Exposures
COVID-19
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Atea Pharmaceuticals Inc (NQ: AVIR )Headline News about Atea Pharmaceuticals Inc
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|